US 10301377
Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
granted A61KA61K2039/53A61K2039/545
Quick answer
US patent 10301377 (Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2039/53, A61K2039/545, A61K2039/55505, A61K2039/55566